Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02523495
NCT02523495UnknownNot Applicable

The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Huazhong University of Science and Technology1 site in 1 country120 target enrollmentStarted: June 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
120
Locations
1
Primary Endpoint
overall survival
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer and explore some biomarkers that relate to target therapy.

Detailed Description

  1. Establish a clinical database of patients who are diagnosed with metastasis colorectal cancer in tongji hospital.
  2. Build a biological specimen banks of metastasis colorectal cancer through collecting blood samples from those patients who have reached an agreement with us.
  3. Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer.
  4. To extract DNA from the blood and explore some biomarkers that related to target therapy in metastasis colorectal cancer.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Metastasis colorectal cancer confirmed by histologically and radiography
  • •Receive target therapy over half a year
  • •Have a measurable lesions

Exclusion Criteria

  • •A history of other malignant tumors in five years

Outcomes

Primary Outcomes

overall survival

Time Frame: 5 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xianglin Yuan

Professor, Chief physician

Huazhong University of Science and Technology

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque PsoriasisPsoriasis
NCT05547490Bristol-Myers Squibb3,506
Recruiting
Not Applicable
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life StudyThyroid Nodules
NCT05189314Columbia University100
Recruiting
Not Applicable
Patterns of Neurodevelopmental DisordersNeurodevelopmental DisordersPediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal InfectionPediatric Acute-Onset Neuropsychiatric SyndromeDown SyndromeMitochondrial EncephalomyopathiesCerebral Folate DeficiencyEpilepsyAutism Spectrum Disorder
NCT06213090Richard Frye1,000
Completed
Not Applicable
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in EuropeSquamous Cell Carcinoma of the Head and Neck
NCT05123950Bristol-Myers Squibb304
Not yet recruiting
Not Applicable
Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS InfectionImmune Dysregulation Disorder
NCT06223100Sichuan Provincial People's Hospital100